RxDoctor Payments Data

Melanie Deitch, OD

Optometrist · Osawatomie, KSNPI 1609378330

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 33.3% of the total. Reporting peaked in 2019 at $370 and has fallen 97.4% since, to $10 in 2025.

$1,022in general payments, 2019–2025

Across 28 payments — averaging $36.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$340
  • Alcon$152
  • Oyster Point Pharma, Inc.$103
  • Johnson & Johnson Vision Care, Inc.$103
  • ABB Con-cise Optical Group LLC$102
  • Coopervision Inc.$94
  • plus $128 from 3 others
$180in research payments, 2019–2025

Across 5 payments — averaging $36.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Notal Vision, Inc.$180

What the payments were for

  • Food & beverage$1,022100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,022 in reported general payments places this provider in the 65th percentile of 567 optometrist providers in Kansas.

See all optometrist providers in Kansas →

Medicare billing

Part B allowed, 2024
$27,896
Medicare patients
168
Services billed
332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost31$94

Paid to pharmacies, not to this prescriber.

Other optometrist in Osawatomie

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →